Tag : Joint Pain

Latest News

High bacterial levels in half of lupus skin rashes

Newsemia
A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of...
Latest News

Woman Starts Eating Animal Brains After Vegan Diet Left Her Weak

Newsemia
A woman who apparently went through 12 years as a vegetarian and 3 more as a vegan started eating meat again after the previous plant-based...
Gastroenterology

New studies point to benefits of weight-loss surgery for teens with severe obesity

Newsemia
Severe obesity affects 4.5 million children and adolescents in the United States, according to the American Academy of Pediatrics. Source link...
Gastroenterology

Botanical product kratom may cause liver toxicity and injury, study finds

Newsemia
Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases –...
Latest News

ACA and chiropractors encourage people to take steps for better musculoskeletal health

Newsemia
The American Chiropractic Association and chiropractors nationwide are encouraging the public to take steps to better musculoskeletal health during National Chiropractic Health Month this October....
Latest News

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Newsemia
Tart cherry reduces the musculoskeletal effects of aromatase inhibitors in patients with non-metastatic breast cancer, according to new findings from a clinical trial by researchers...
Neurology

FDA Approves First Vaccine for Dengue, With Restrictions

Newsemia
Dengvaxia is for the prevention of dengue disease caused by all dengue virus serotypes in people aged 9 to 16 years who have previously had...
Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

FDA expands label for VENCLEXTA to include information about patients with previously-treated CLL

Newsemia
AbbVie, a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration has expanded the label for VENCLEXTA® in combination with rituximab to...
Latest News

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

Newsemia
The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML)...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy